Zheng Qi 2021-04-16
Core Treatment Principle
The standard first-line treatment for soil-transmitted helminth infections relies on a single oral dose of one of four WHO-recommended safe, cost-effective anthelmintic drugs, which have been widely validated in global public health campaigns with minimal side effects for all eligible populations. For residents living in high-prevalence STH endemic areas, regular preventive deworming twice a year is strongly recommended, as this routine intervention can reduce local STH infection prevalence by over 70% within two years, effectively cutting off the chronic transmission cycle in the community.
Age-Specific Dosage Guidelines
For Albendazole 400 mg tablets, children aged 1 to 2 years take half a tablet per treatment, while all people aged 2 years and above take one full tablet. For Mebendazole 500 mg tablets, children aged 1 to 2 years take one full tablet, and the same single full tablet dose applies to all people aged 2 years and above.
For Levamisole 40 mg tablets, children aged 1 to 5 years follow a 2.5mg per kilogram body weight dosing rule, children aged 1 to 12 years take 2 tablets per treatment, and people aged 12 years and above also follow the 2.5mg per kilogram body weight standard. For Pyrantel 250 mg tablets, all children aged 1 to 12 years take a single dose calculated at 10mg per kilogram of body weight.
Key Clinical Notes
All these four drugs are proven to be highly effective against the three most common STH species (roundworm, hookworm, whipworm), with cure rates ranging from 85% to 95% under standard dosing. Mild, transient side effects such as slight abdominal discomfort or mild dizziness may occur in less than 5% of patients with heavy worm burdens, and these symptoms usually resolve completely within 24 hours without additional medical intervention. Pregnant women in their second and third trimesters can safely receive these standard treatments under the guidance of local community health workers, which helps prevent STH-related anemia and adverse pregnancy outcomes.
Edited by: Secretariat of the Asia-Pacific Network for Drug and Diagnostics Innovation
Produced by: Zheng Qi
Reviewed by: Zhang Haobing
Tel: 021-64377008-2510 Fax: 021-54108329
Address: 207 Ruijin 2nd Road, Huangpu District,Shanghai, P.R. China Postcode: 200025